{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:01:48Z","timestamp":1722888108400},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1981,9,1]],"date-time":"1981-09-01T00:00:00Z","timestamp":368150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blut"],"published-print":{"date-parts":[[1981,9]]},"DOI":"10.1007\/bf00363890","type":"journal-article","created":{"date-parts":[[2004,11,2]],"date-time":"2004-11-02T08:09:36Z","timestamp":1099382976000},"page":"201-211","source":"Crossref","is-referenced-by-count":17,"title":["Clinical and prognostic heterogeneity of non-hodgkin lymphomas of high-grade malignancy"],"prefix":"10.1007","volume":"43","author":[{"given":"U.","family":"Schmalhorst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Boll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Burger-Sch\ufffdler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Common","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. H.","family":"F\ufffdlle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Graubner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Leopold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Meusers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"N\ufffdrnberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"R\ufffdhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schoengen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Strassner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.-W.","family":"Schwarze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Brittinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Kiel Lymphoma Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-76-2-227","volume":"76","author":"CM Bagley Jr","year":"1972","unstructured":"Bagley CM Jr, DeVita VT Jr, Berard CW, Canellos GP (1972) Advanced lymphosarcoma: Intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. Ann Intern Med 76: 227?234","journal-title":"Ann Intern Med"},{"key":"CR2","first-page":"211","volume-title":"Lymphknotentumoren, Pathophysiologie, Klinik und Therapie","author":"H Bartels","year":"1979","unstructured":"Bartels H, Burger A, Common H, Donhuijsen-Ant R, Graubner M, Grupp HJ, Huhn D, Leopold H, Nowicki L, N\u00fcrnberger R, R\u00fchl U, Waldner R (Kieler Lymphomgruppe) (1979) Klinik und Prognose des centroblastisch-centrocytischen Lymphoms und des centroblastischen Lymphoms. In: Stacher A, H\u00f6cker P (Hrsg) Lymphknotentumoren, Pathophysiologie, Klinik und Therapie. Urban u. Schwarzenberg, M\u00fcnchen Wien Baltimore, S 211?217"},{"key":"CR3","first-page":"89","volume-title":"Advances in Medical Oncology, Research and Education","author":"DE Bergsagel","year":"1979","unstructured":"Bergsagel DE, Gospodarowicz M, Bush R, Brown TC (1979) Non-Hodgkin's lymphomas: A search for prognostic factors. In: Canonico A, Estevez O, Chacon R, Barg S (eds) Advances in Medical Oncology, Research and Education; Proceedings of the 12th International Cancer Congress Buenos Aires 1978, vol VII: Crowther DG (ed) Leukemia and Non-Hodgkin Lymphoma. Pergamon Press, Oxford New York Toronto Sydney Paris Frankfurt, pp 89?98"},{"key":"CR4","first-page":"211","volume-title":"Maligne Lymphome und monoklonale Gammopathien. H\u00e4matologie und Bluttransfusion, Vol 18","author":"G Brittinger","year":"1976","unstructured":"Brittinger G, Bartels H, Bremer K, D\u00fchmke E, Gunzer U, K\u00f6nig E, Stein H (Kieler Lymphomgruppe) (1976) Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kiel-Klassifikation: Centrocytisches Lymphom, centroblastisch-centrocytisches Lymphom, lymphoblastisches Lymphom, immunoblastisches Lymphom. In: L\u00f6ffler H (Hrsg) Maligne Lymphome und monoklonale Gammopathien. H\u00e4matologie und Bluttransfusion, Vol 18. Lehmann, M\u00fcnchen, S 211?223"},{"key":"CR5","volume-title":"Lymphoid neoplasias II: Clinical and therapeutic aspects","author":"G Brittinger","year":"1978","unstructured":"Brittinger G (for the Kiel Lymphoma Study Group) (1978) Outline of a prospective multicentric study on the clinical significance of the Kiel classification of non-Hodgkin's lymphomas. In: Math\u00e9 G, Seligmann M, Tubiana M (eds) Lymphoid neoplasias II: Clinical and therapeutic aspects. Springer, Berlin Heidelberg New York (Recent Results in Cancer Research, vol 65, pp 197?202)"},{"key":"CR6","first-page":"175","volume-title":"Controversies in cancer: Design of trials and treatment","author":"G Brittinger","year":"1979","unstructured":"Brittinger G, Schmalhorst U, Bartels H, Br\u00fccher H, Common H, D\u00fchmke E, F\u00fclle HH, Gunzer U, Huhn D, K\u00f6nig E, Lennert K, Leopold H, Meusers P, Nowicki L, Pralle H, Stacher A, Theml H (Kiel Lymphoma Study Group) (1979) Clinical relevance of the Kiel classification of non-Hodgkin lymphomas: Preliminary results of a prospective multicentric study. In: Tagnon HJ, Staquet MJ (eds) Controversies in cancer: Design of trials and treatment. Masson, New York Paris, pp 175?187"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00363886","volume":"43","author":"G Brittinger","year":"1981","unstructured":"Brittinger G, Schmalhorst U, Bartels H, F\u00fclle HH, Gerhartz H, Gremmel G, Grisar T, Grupp HJ, Gunzer U, Huhn D, Koeppen K-M, Kubanek B, Leopold H, L\u00f6ffler H, L\u00f6hr GW, Nowicki L, R\u00fchl U, Schmidt M, Stacher A, Theml H, Lennert K (Kiel Lymphoma Study Group) (1981) Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classification. Blut 43: 155?166","journal-title":"Blut"},{"key":"CR8","first-page":"229","volume-title":"Advances in Medical Oncology, Research, and Education","author":"G Brittinger","year":"1979","unstructured":"Brittinger G, Schmalhorst U, Bartels H, Bremer K, Brunswicker F, Burger A, Common H, D\u00fchmke E, F\u00fclle HH, Heinz R, Huber H, K\u00f6nig E, Koeppen K-M, Leopold H, Meusers P, Nowicki L, N\u00fcrnberger R, Oertel J, Pees HW, Pfoch M, Pralle H, Schmidt M (1979) Chemotherapy of non-Hodgkin's lymphomas ? Indications and results. In: Canonico A, Estevez O, Chacon R, Barg S (eds) Advances in Medical Oncology, Research, and Education; Proceedings of the 12th International Cancer Congress Buenos Aires 1978, vol. VII: Leukemia and Non-Hodgkin Lymphoma. Pergamon Press, Oxford New York Toronto Sydney Paris Frankfurt, pp 229?241"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/1097-0142(197808)42:2+<932::AID-CNCR2820420716>3.0.CO;2-2","volume":"42","author":"GP Canellos","year":"1978","unstructured":"Canellos GP, Lister TA, Skarin AT (1978) Chemotherapy of the non-Hodgkin's lymphomas. Cancer 42: 932?940","journal-title":"Cancer"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0021-9681(58)90126-7","volume":"8","author":"SJ Cutler","year":"1958","unstructured":"Cutler SJ, Ederer F (1958) Maximum utilization of the life table method in analyzing survival. J Chronic Dis 8: 699?712","journal-title":"J Chronic Dis"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01477249","volume":"56","author":"H Delbr\u00fcck","year":"1978","unstructured":"Delbr\u00fcck H, Weichert HC, Schmitt G, Firusian N, Wetter O (1978) Der Zusammenhang zwischen Prognose und Kieler Klassifikation der malignen Non-Hodgkin-Lymphome. Klin Wochenschr 56: 539?543","journal-title":"Klin Wochenschr"},{"key":"CR12","first-page":"39","volume-title":"Recent advances in cancer treatment","author":"VT Vita De Jr","year":"1977","unstructured":"DeVita VT Jr, Fisher RI, Young RC (1977) Treatment of diffuse histiocytic lymphomas: New opportunities for the future. In: Tagnon HJ, Staquet MJ (eds) Recent advances in cancer treatment. Raven Press, New York, pp 39?54"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1002\/1097-0142(197906)43:6<2540::AID-CNCR2820430655>3.0.CO;2-D","volume":"43","author":"L Elias","year":"1979","unstructured":"Elias L (1979) Differences in age and sex distribution among patients with non-Hodgkin's lymphoma. Cancer 43: 2540?2546","journal-title":"Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9343(77)90230-3","volume":"63","author":"RI Fisher","year":"1977","unstructured":"Fisher RI, DeVita VT, Johnson BL, Simon R, Young RC (1977) Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med 63: 177?182","journal-title":"Am J Med"},{"key":"CR15","first-page":"229","volume-title":"Lymphknotentumoren, Pathophysiologie, Klinik und Therapie","author":"U Gunzer","year":"1979","unstructured":"Gunzer U, Bartels H, Burger A, Common H, Dabag S, F\u00fclle HH, Huhn D, Leopold H, L\u00f6ffler H, Nowicki L, Vogt W, Waldner R (Kieler Lymphomgruppe) (1979) Klinik und Prognose des lymphoblastischen Lymphoms. In: Stacher A, H\u00f6cker P (Hrsg) Lymphknotentumoren, Pathophysiologie, Klinik und Therapie. Urban u. Schwarzenberg, M\u00fcnchen Wien Baltimore, S 229?233"},{"key":"CR16","first-page":"388","volume":"8","author":"DA Karnofsky","year":"1948","unstructured":"Karnofsky DA, Burchenal JH (1948) The evaluation of chemotherapeutic agents against neoplastic disease. Cancer Res 8: 388?389","journal-title":"Cancer Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00363887","volume":"43","author":"GRF Kr\u00fcger","year":"1981","unstructured":"Kr\u00fcger GRF, Grisar T, Lennert K, Schwarze E-W, Brittinger G (Kiel Lymphoma Study Group) (1981) Histopathological correlation of the Kiel with the original Rappaport classification of malignant non-Hodgkin lymphomas. Blut 43: 167?181","journal-title":"Blut"},{"key":"CR18","volume-title":"Handbuch der speziellen pathologischen Anatomie und Histologie, 1. Band, Teil 3 B","author":"K Lennert","year":"1978","unstructured":"Lennert K (1978) Malignant lymphomas other than Hodgkin's disease. Handbuch der speziellen pathologischen Anatomie und Histologie, 1. Band, Teil 3 B. Springer, Berlin Heidelberg New York"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0014-2964(78)90263-3","volume":"14","author":"C Meug\u00e9","year":"1977","unstructured":"Meug\u00e9 C, Hoerni B, DeMascarel A, Durant M, Richaud P, Hoerni-Simon G, Chauvergne J, Lagarde C (1977) Non-Hodgkin malignant lymphomas. Clinico-pathologic correlations with the Kiel classification. Eur J Cancer 14: 587?592","journal-title":"Eur J Cancer"},{"key":"CR20","first-page":"224","volume-title":"Lymphknotentumoren, Pathophysiologie, Klinik und Therapie","author":"P Meusers","year":"1979","unstructured":"Meusers P, Bremer K, Bartels H, Brunswicker F, Burger A, Common H, Heinz R, Leopold H, L\u00f6ffler H, Nowicki L, Vogt W, Waldner R, (Kieler Lymphomgruppe) (1979) Klinik und Prognose des immunoblastischen Lymphoms. In: Stacher A, H\u00f6cker P (Hrsg) Lymphknotentumoren, Pathophysiologie, Klinik und Therapie. Urban u. Schwarzenberg, M\u00fcnchen Wien Baltimore, S 224?228"},{"key":"CR21","first-page":"384","volume":"301","author":"P Meusers","year":"1979","unstructured":"Meusers P, Bartels H, Brittinger G, Common H, D\u00fchmke E, F\u00fclle HH, Gunzer U, Heinz R, K\u00f6nig E, Musshoff K, Pralle H, Schmalhorst U, Theml H, Kr\u00fcger GRF, Lennert K (Kiel Lymphoma Study Group) (1979) Heterogeneity of diffuse ?histiocytic? lymphoma according to the Kiel classification. N Engl J Med 301: 384","journal-title":"N Engl J Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00573019","volume":"83","author":"K Musshoff","year":"1975","unstructured":"Musshoff K, Schmidt-Vollmer H (1975) Prognosis of non-Hodgkin's lymphomas with special emphasis on the staging classification. Z Krebsforsch 83: 323?341","journal-title":"Z Krebsforsch"},{"key":"CR23","first-page":"1049","volume":"61","author":"CS Portlock","year":"1977","unstructured":"Portlock CS, Rosenberg SA (1977) Chemotherapy of the non-Hodgkin's lymphomas: The Stanford experience. Cancer Treat Rep 61: 1049?1055","journal-title":"Cancer Treat Rep"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJM197812212992503","volume":"299","author":"JA Strauchen","year":"1978","unstructured":"Strauchen JA, Young RC, DeVita VT, Anderson T, Fantone JC, Berard CW (1978) Clinical relevance of the histopathological subclassification of diffuse ?histiocytic? lymphoma. N Engl J Med 299: 1382?1387","journal-title":"N Engl J Med"}],"container-title":["Blut"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00363890.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00363890\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00363890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T22:27:06Z","timestamp":1554762426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00363890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1981,9]]}},"alternative-id":["BF00363890"],"URL":"https:\/\/doi.org\/10.1007\/bf00363890","relation":{},"ISSN":["0006-5242","1432-0584"],"issn-type":[{"type":"print","value":"0006-5242"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[1981,9]]}}}